Now Reading: New rules let India debar pharma firms for fake data
-
01
New rules let India debar pharma firms for fake data
The Union Health Ministry has amended the Drugs Rules, 1945, to empower licensing authorities to debar entities that submit fake or fabricated data in drug applications. The new rule, notified on Thursday,…
The Story in Brief
The Union Health Ministry has amended the Drugs Rules, 1945, to empower licensing authorities to debar entities that submit fake or fabricated data in drug applications. The new rule, notified on Thursday, allows a temporary ban on fresh applications from such entities for a specified period.
Earlier, offenders faced only rejection of applications or cancellation of existing licences. The Ministry said the changes aim to strengthen accountability and ensure drug approvals rely on scientifically valid evidence. A show-cause notice is required before any debarment, and an appeal mechanism exists.
The Indian Opinion
Pharma companies cutting corners are common in India. The new debarment rule is welcome, but the ministry must show it will use it. A slap on the wrist will not change behaviour. The real test will be the first high-profile case: will a big player face a ban, or only small firms?
Source: thehindu.com
This story was synthesised by AI from the source linked above.
Updated: this story now draws on 1 sources.
